Bliss GVS Pharma Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Bliss GVS Pharma Limited Company Profile :

Bliss GVS Pharma Limited is an Indian company engaged in developing, manufacturing and marketing pharmaceutical formulations.

The Company offers a range of suppositories and pessaries in various therapeutic categories, including women’s health, which consists of anti-fungal, anti-bacterial, contraceptive and lubricants; gastro-intestinal basket, which consists of anti-hemorrhoid, laxatives, anti-inflammatory and anti-emetic, and anti-malarial, which consists of artesunate suppositories.


Bliss GVS Pharma ResultsBSE Code : 506197
NSE Symbol : BLISSGVS
ISIN No. : INE416D01022
Industry : Pharmaceuticals
Face Value : Rs. 1.00


If you are an investor who has shares of Bliss GVS Pharma or you are an stock market analyst then i am sure you might for Quarterly Results of Bliss GVS Pharma.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Bliss GVS Pharma. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of v.

Bliss GVS Pharma Q1 Results 2016-17 :

Bliss GVS Pharma will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income  –
Total Income
Expenditure
Interest  –
Depreciation  –
PBT
Tax
Net Profit
Equity  –
EPS  –

Bliss GVS Pharma will announce its Q2 FY 2016-17 Results in the month of October 2016.

Bliss GVS Pharma will announce its Q3 FY 2016-17 Results in the month of January 2017.

Bliss GVS Pharma will announce its Q4 FY 2016-17 Results in the month of April 2017.

Bliss GVS Pharma will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Bliss GVS Pharma Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue  326.38 546.89
Other Income  23.08 24.35
Total Income  349.46 571.24
Expenditure  -230.29 -404.85
Interest  -13.11 -18.19
Depreciation  -5.85 -13.26
PBT  100.21 148.19
Tax  -34.60 -48.04
Net Profit  65.62 100.14
Equity  10.32 10.32
EPS  6.36 8.00

Note : If you like this information about Bliss GVS Pharma Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.